As The World Turns: Cash Raised In France Could Get Vaccines Developed In Cuba Marketed In Asia
This article was originally published in The Pink Sheet Daily
Executive Summary
Abivax’s record-breaking IPO will support development of a therapeutic vaccine against hepatitis B and an antiviral against HIV/AIDS, and the distribution of a series of Cuba-marketed vaccines in Asia.